Drawing for VPLAB WITHOUT COMPROMISE

USPTO serial 79355068

VPLAB WITHOUT COMPROMISE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
O'BRIEN, JENNIFER LYNN
Law office
TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VPLAB WITHOUT COMPROMISE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietetic substances adapted for medical use; nutritive substances for microorganisms; mineral waters for medical purposes; dietary fibre; haematogen; glycerophosphates; glucose for medical purposes; hormones for medical purposes; vitamin supplement patches; mineral dietary supplements; nutritional supplements; albumin dietary supplements; yeast dietary supplements; alginate dietary supplements; glucose dietary supplements; casein dietary supplements; lecithin dietary supplements; linseed oil dietary supplements; propolis dietary supplements; protein dietary supplements; royal jelly dietary supplements; pollen dietary supplements; wheat germ dietary supplements; linseed dietary supplements; acai powder dietetic supplements; dietary supplements with a cosmetic effect; enzyme dietary supplements; yeast for pharmaceutical purposes; gelatine for medical purposes; cod liver oil; immunostimulants; capsules for medicines; cachets for pharmaceutical purposes; acids for pharmaceutical purposes; collagen for medical purposes; medicated sweets; barks for pharmaceutical purposes; starch for dietetic or pharmaceutical purposes; cultures of microorganisms for medical or veterinary use; liquorice for pharmaceutical purposes; milk sugar for pharmaceutical purposes; lecithin for medical purposes; ointments for pharmaceutical purposes; almond milk for pharmaceutical purposes; powdered milk for babies; royal jelly for pharmaceutical purposes; milk ferments for pharmaceutical purposes; flour for pharmaceutical purposes; linseed meal for pharmaceutical purposes; fish meal for pharmaceutical purposes; freeze-dried meat adapted for medical purposes; dietetic beverages adapted for medical purposes; malted milk beverages for medical purposes; pastilles for pharmaceutical purposes; pectin for pharmaceutical purposes; pepsins for pharmaceutical purposes; peptones for pharmaceutical purposes; food for babies; albuminous preparations for medical purposes; biological preparations for medical purposes; vitamin preparations; preparations of microorganisms for medical or veterinary use; preparations of trace elements for human and animal use; enzyme preparations for veterinary purposes; phytotherapy preparations for medical purposes; albuminous foodstuffs for medical purposes; dietetic foods adapted for medical purposes; by-products of the processing of cereals for dietetic or medical purposes; homogenized food adapted for medical purposes; freeze-dried food adapted for medical purposes; syrups for pharmaceutical purposes; lacteal flour for babies; infant formula; malt for pharmaceutical purposes; appetite suppressants for medical purposes; medical preparations for slimming purposes; purgatives; sedatives; digestives for pharmaceutical purposes; nervines; steroids; suppositories; serums; appetite suppressant pills; slimming pills; jujube, medicated; antioxidant pills; enzymes for medical purposes; medicinal tea; herbal teas for medicinal purposes; herbal extracts for medical purposes; elixirs [pharmaceutical preparations]ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 22, 2025FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 3, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB
Mar 2, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 7, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 12, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 1, 2024MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 1, 2024MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 1, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 28, 2023RFNTREFUSAL PROCESSED BY IB
Aug 12, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 9, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 9, 2023RFRRREFUSAL PROCESSED BY MPU
Jul 6, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 5, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2023DOCKASSIGNED TO EXAMINER
Nov 19, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Nov 15, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 10, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance